Preterm Infants on Early Solid Foods
Кључне речи
Апстрактан
Опис
Aim: In a prospective, randomized, two arm intervention study- the PIES project- we aim to investigate the impact of different time points of introduction of complementary food on growth, body composition, atopic disease and neurodevelopmental outcome in preterm infant with a birth weight <1500 grams. Furthermore, we want to investigate whether a certain standardized feeding protocol meets the nutritional needs of premature infants, and obtain data on safety and efficacy in this context. Methods: At term infants are stratified according to breastfed or formula fed and randomized in one of the following groups: an EARLY complementary feeding group (introduction of complementary food between the 10th and 12th week of life corrected for term, n=76) and LATE complementary feeding group (introduction of complementary food between the 16th and 18th week of life corrected for term, n=76). The infants will be fed with standardized complementary food in addition to formula or breastfeeding until they are one year corrected for prematurity. In an age dependent step up concept, food boxes are delivered to the parents: five types of standardized food boxes with manifold complementary food according to the infants' age and the ability to tolerate small pieces are available for each child during the study. The standardized complementary feeding regimen allows calculating exact intake of nutrients and therefore will provide information concerning primary and secondary outcome. The follow up phase will last until 5 years of age. Within regular visits anthropometric data (height, head circumference, weight, BMI and z-scores ) and body composition via the PeaPod® system will be gathered. Data on atopy will be assessed by clinical scoring system SCORAD (SCORing Atopic Dermatitis) and the laboratory parameters Fx5(Fx5 test uses six food allergens: wheat, egg, cow's milk, soya, peanut and fish) and IgE (immuneglobulineE). Neurodevelopmental outcome will be assessed at the age of one and two years corrected for term by the Bayley Scales and the K-ABC (Kaufman Assessment Battery for Children). The nutritional concept will be monitored concerning short term safety and efficacy (bone metabolism, iron status, protein- and lipid status) as well as regarding long term outcome (diabetes and obesity markers IGF-1 (Insulin-like growth factor-1, adiponectin and leptin).
With the PIES project we intend to close a gap of knowledge in feeding the premature infant during the first year of life and to understand the impact of complementary feeding on growth, atopy, neurodevelopmental outcome and later obesity.
Датуми
Последња верификација: | 02/28/2019 |
Фирст Субмиттед: | 02/28/2013 |
Предвиђена пријава послата: | 03/08/2013 |
Прво објављено: | 03/11/2013 |
Послато последње ажурирање: | 03/18/2019 |
Последње ажурирање објављено: | 03/20/2019 |
Стварни датум почетка студије: | 09/30/2013 |
Процењени датум примарног завршетка: | 02/27/2020 |
Предвиђени датум завршетка студије: | 11/30/2024 |
Стање или болест
Интервенција / лечење
Other: Early complementary feeding group
Other: Late complementary feeding group:
Фаза
Групе руку
Арм | Интервенција / лечење |
---|---|
Experimental: Early complementary feeding group Early intervention group:
Introduction of early complementary feedings between the 10th -12th week of gestation corrected for prematurity | Other: Early complementary feeding group solid food will be introduced between week 10 and 12 |
Experimental: Late complementary feeding group: Late intervention group:
Introduction of late complementary feedings between the 16th and 18th week of life corrected for prematurity | Other: Late complementary feeding group: solid food is introduced between 16-18th week of gestation corrected for prematurity |
Критеријуми
Полови подобни за студирање | All |
Прихвата здраве волонтере | да |
Критеријуми | Inclusion Criteria: - Preterm infants <1500 gram - Informed consent Exclusion Criteria: Diseases affecting stable growth: - Gastrointestinal diseases: necrotizing enterocolitis, Hirschsprung disease, chronic inflammatory bowel disease - Bronchopulmonary dysplasia (BPD) defined as oxygen demand above 36 week gestational age - Congenital heart diseases - major congenital birth defects - chromosomal aberrations |
Исход
Примарне мере исхода
1. Height: [1 Year]
Секундарне мере исхода
1. neurodevelopmental outcome [5 years]
2. IGF-1 [5 years]
3. FX5 [5 years]
4. SCORAD [5 years]
5. Body composition [5 years]
6. Vitamin D [1 year]
7. Iron status [1 year]
8. Leptin [5 years]
9. BMI [5 years]
10. weight [5 years]
11. head circumference [5 years]
12. z-scores [5 years]